The 3D Cell Culture Market is being driven by Increase in infectious diseases
The 3D Cell Culture Market is expected to grow at a CAGR of 16.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1382.4 million. Monoclonal antibodies, derived from identical immune cells, are a significant growth driver in the pharmaceutical sector, with applications spanning biology, diagnostic imaging, medicine, and biochemistry. Medical applications encompass cancer, multiple sclerosis, rheumatoid arthritis, cardiovascular diseases, Crohn's disease, psoriasis, and ulcerative colitis. The escalating demand for monoclonal antibodies necessitates the development and provision of advanced production technologies. With the increasing prevalence of chronic diseases and other health concerns, the antibiotic treatment sector experiences significant growth. Major players in the industry have established large-scale manufacturing facilities, equipped with numerous 3D cell culture bioreactors, to meet the surging demand for monoclonal antibodies, thereby fueling the expansion of the global 3D cell culture market.
Get more information on 3D Cell Culture Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
135 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 16.6% |
Market growth 2024-2028 |
USD 1382.4 million |
Market structure |
market_structure.ucfirst |
YoY growth 2023-2024(%) |
13.9 |
Key countries |
US, Germany, UK, China, and Canada |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The global 3D cell culture market is experiencing significant growth due to the innovation and adoption of advanced biotechnology in research laboratories. Pharmaceutical companies are increasingly investing in 3D scaffold-based techniques for cell culture to better mimic the natural microenvironment, leading to more effective drug development and applications. This market is expected to continue expanding with the introduction of new products and techniques.
The 3D cell culture market is a significant segment of the global life science tools and services industry, which encompasses companies and products involved in the research, development, and production of equipment, consumables, and services for pharmaceuticals, biotechnology, and diagnostic applications. Key drivers for market expansion include the rising prevalence of chronic diseases, such as cancer, and the increasing demand for advanced research tools for drug discovery and stem cell research. Technavio projects that the adoption of 3D cell culture technologies, including scaffolds, hydrogels, and bioreactors, will be fueled by the need for more accurate and efficient disease modeling and the development of novel therapeutics. These advancements will contribute to the overall growth of the life science tools and services market, which is expected to reach substantial revenue by 2027.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted